Analyst Ratings for Lifecore Biomedical
Analyst Ratings for Lifecore BiomedicalLifecore 生物医学的分析师评级
Lifecore Biomedical (NASDAQ:LFCR) has observed the following analyst ratings within the last quarter:
According to 4 analyst offering 12-month price targets in the last 3 months, Lifecore Biomedical has an average price target of $7.25 with a high of $11.00 and a low of $2.00.
Below is a summary of how these 4 analysts rated Lifecore Biomedical over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock
This current average has decreased by 29.82% from the previous average price target
风险提示：以上内容仅作为作者或者嘉宾的观点，不代表富途的任何立场，不构成与富途相关的任何投资建议。在作出任何投资决定前，投资者应根据自身情况考虑投资产品相关的风险因素，并于需要时咨询专业投资顾问意见。富途竭力但不能证实上述内容的真实性、准确性和原创性，对此富途不做任何保证和承诺。